The molecular mechanisms underlying pathogenesis in the majority of sporadic Alzheimer's disease (SAD) cases are largely unknown;complex interactions between multiple environmental factors, such as diet and life style, along with genetic factors are all significant contributors. Classic cardio-metabolic risk factors such as hypertension, diabetes mellitus, and hypercholesterolemia have also been shown to increase the risk of SAD with several common features, including insulin resistance, neuroinflammation and endothelial dysfunction. Our pilot study indicates that combination of a typical Western diet (TWD) with physiologically relevant high cholesterol content with mice deficient in vascular nitric oxide synthase gene (eNOS) induces significant AD-like phenotypes including increased amyloidogenesis, metabolic changes and neuroinflammation. We hypothesize that by combining the global vascular risk factor with long-term TWD (>8 months), we will create a representative non-transgenic mouse model for SAD in middle-aged non-transgenic C57BL/6 mice. To test this hypothesis, two specific aims are proposed accordingly to 1) determine the effects of a TWD in eNOS-deficient mice (eNOS-/- and eNOS+/-) on AD-related cognitive measures by various behavioral tests and 2) to comprehensively characterize AD-like phenotypes in the selected diet model. Given our success, the model will provide a useful tool to unravel further mechanistic associations between cardiovascular diseases, diabetes and AD. Validation of a number of identified diabetic genes as AD risk genes will encourage us to use this model in the future to conduct a genome- wide gene analysis to identify new vascular-metabolic risk genes for AD.
Development of a diet-induced mouse model to incorporate both vascular risk factor and metabolic disturbance (from unhealthy eating habits) will be very useful for future identification of novel AD risk genes and study mechanistic associations between cardiovascular diseases, diabetes and AD.
|Kim, Eunhee; Wang, Bin; Sastry, Namratha et al. (2016) NEDD4-mediated HSF1 degradation underlies Î±-synucleinopathy. Hum Mol Genet 25:211-22|
|Li, Jing Jing; Ferry Jr, Robert J; Diao, Shiyong et al. (2015) Nedd4 haploinsufficient mice display moderate insulin resistance, enhanced lipolysis, and protection against high-fat diet-induced obesity. Endocrinology 156:1283-91|
|Wang, Ruishan; Chen, Shaoya; Liu, Yingchun et al. (2015) All-trans-retinoic acid reduces BACE1 expression under inflammatory conditions via modulation of nuclear factor ÎºB (NFÎºB) signaling. J Biol Chem 290:22532-42|
|Tan, Xing-Lin; Xue, Yue-Qiang; Ma, Tao et al. (2015) Partial eNOS deficiency causes spontaneous thrombotic cerebral infarction, amyloid angiopathy and cognitive impairment. Mol Neurodegener 10:24|
|Li, Jing Jing; Dolios, Georgia; Wang, Rong et al. (2014) Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression. PLoS One 9:e90770|
|Mayo, Jamie N; Chen, Cheng-Hung; Liao, Francesca-Fang et al. (2014) Homocysteine disrupts outgrowth of microvascular endothelium by an iNOS-dependent mechanism. Microcirculation 21:541-50|
|Chen, Yaomin; Wang, Bin; Liu, Dan et al. (2014) Hsp90 chaperone inhibitor 17-AAG attenuates AÎ²-induced synaptic toxicity and memory impairment. J Neurosci 34:2464-70|
|Zhang, Yun-wu; Chen, Yaomin; Liu, Yun et al. (2013) APP regulates NGF receptor trafficking and NGF-mediated neuronal differentiation and survival. PLoS One 8:e80571|
|Wang, Ruishan; Li, Jing Jing; Diao, Shiyong et al. (2013) Metabolic stress modulates Alzheimer's Ã½Ã½-secretase gene transcription via SIRT1-PPARÃ½Ã½-PGC-1 in neurons. Cell Metab 17:685-94|